Global and Japan Infection Prevention and Enteral Access Market Insights, Forecast to 2026
1 Study Coverage
- 1.1 Infection Prevention and Enteral Access Product Introduction
- 1.2 Market Segments
- 1.3 Key Infection Prevention and Enteral Access Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Type
- 1.4.2 Enteral Feeding Pumps
- 1.4.3 Enteral Feeding Tubes
- 1.4.4 Administration Reservoirs
- 1.4.5 Giving Sets
- 1.4.6 Enteral Syringes
- 1.5 Market by Application
- 1.5.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Application
- 1.5.2 Oncology
- 1.5.3 Gastroenterology
- 1.5.4 Diabetes
- 1.5.5 Neurological Disorders
- 1.5.6 Hypermetabolism
- 1.5.7 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Infection Prevention and Enteral Access Market Size, Estimates and Forecasts
- 2.1.1 Global Infection Prevention and Enteral Access Revenue 2015-2026
- 2.1.2 Global Infection Prevention and Enteral Access Sales 2015-2026
- 2.2 Global Infection Prevention and Enteral Access, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Infection Prevention and Enteral Access Historical Market Size by Region (2015-2020)
- 2.3.1 Global Infection Prevention and Enteral Access Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Infection Prevention and Enteral Access Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Infection Prevention and Enteral Access Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Infection Prevention and Enteral Access Sales Forecast by Region (2021-2026)
- 2.4.2 Global Infection Prevention and Enteral Access Revenue Forecast by Region (2021-2026)
3 Global Infection Prevention and Enteral Access Competitor Landscape by Players
- 3.1 Global Top Infection Prevention and Enteral Access Sales by Manufacturers
- 3.1.1 Global Infection Prevention and Enteral Access Sales by Manufacturers (2015-2020)
- 3.1.2 Global Infection Prevention and Enteral Access Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Infection Prevention and Enteral Access Manufacturers by Revenue
- 3.2.1 Global Infection Prevention and Enteral Access Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Infection Prevention and Enteral Access Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Infection Prevention and Enteral Access Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Infection Prevention and Enteral Access Revenue in 2019
- 3.2.5 Global Infection Prevention and Enteral Access Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Infection Prevention and Enteral Access Price by Manufacturers
- 3.4 Global Infection Prevention and Enteral Access Manufacturing Base Distribution, Product Types
- 3.4.1 Infection Prevention and Enteral Access Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Infection Prevention and Enteral Access Product Type
- 3.4.3 Date of International Manufacturers Enter into Infection Prevention and Enteral Access Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Infection Prevention and Enteral Access Market Size by Type (2015-2020)
- 4.1.1 Global Infection Prevention and Enteral Access Sales by Type (2015-2020)
- 4.1.2 Global Infection Prevention and Enteral Access Revenue by Type (2015-2020)
- 4.1.3 Infection Prevention and Enteral Access Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Infection Prevention and Enteral Access Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Infection Prevention and Enteral Access Sales Forecast by Type (2021-2026)
- 4.2.2 Global Infection Prevention and Enteral Access Revenue Forecast by Type (2021-2026)
- 4.2.3 Infection Prevention and Enteral Access Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Infection Prevention and Enteral Access Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Infection Prevention and Enteral Access Market Size by Application (2015-2020)
- 5.1.1 Global Infection Prevention and Enteral Access Sales by Application (2015-2020)
- 5.1.2 Global Infection Prevention and Enteral Access Revenue by Application (2015-2020)
- 5.1.3 Infection Prevention and Enteral Access Price by Application (2015-2020)
- 5.2 Infection Prevention and Enteral Access Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Infection Prevention and Enteral Access Sales Forecast by Application (2021-2026)
- 5.2.2 Global Infection Prevention and Enteral Access Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Infection Prevention and Enteral Access Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
- 6.1 Japan Infection Prevention and Enteral Access Market Size YoY Growth 2015-2026
- 6.1.1 Japan Infection Prevention and Enteral Access Sales YoY Growth 2015-2026
- 6.1.2 Japan Infection Prevention and Enteral Access Revenue YoY Growth 2015-2026
- 6.1.3 Japan Infection Prevention and Enteral Access Market Share in Global Market 2015-2026
- 6.2 Japan Infection Prevention and Enteral Access Market Size by Players (International and Local Players)
- 6.2.1 Japan Top Infection Prevention and Enteral Access Players by Sales (2015-2020)
- 6.2.2 Japan Top Infection Prevention and Enteral Access Players by Revenue (2015-2020)
- 6.3 Japan Infection Prevention and Enteral Access Historic Market Review by Type (2015-2020)
- 6.3.1 Japan Infection Prevention and Enteral Access Sales Market Share by Type (2015-2020)
- 6.3.2 Japan Infection Prevention and Enteral Access Revenue Market Share by Type (2015-2020)
- 6.3.3 Japan Infection Prevention and Enteral Access Price by Type (2015-2020)
- 6.4 Japan Infection Prevention and Enteral Access Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 Japan Infection Prevention and Enteral Access Sales Forecast by Type (2021-2026)
- 6.4.2 Japan Infection Prevention and Enteral Access Revenue Forecast by Type (2021-2026)
- 6.4.3 Japan Infection Prevention and Enteral Access Price Forecast by Type (2021-2026)
- 6.5 Japan Infection Prevention and Enteral Access Historic Market Review by Application (2015-2020)
- 6.5.1 Japan Infection Prevention and Enteral Access Sales Market Share by Application (2015-2020)
- 6.5.2 Japan Infection Prevention and Enteral Access Revenue Market Share by Application (2015-2020)
- 6.5.3 Japan Infection Prevention and Enteral Access Price by Application (2015-2020)
- 6.6 Japan Infection Prevention and Enteral Access Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 Japan Infection Prevention and Enteral Access Sales Forecast by Application (2021-2026)
- 6.6.2 Japan Infection Prevention and Enteral Access Revenue Forecast by Application (2021-2026)
- 6.6.3 Japan Infection Prevention and Enteral Access Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Infection Prevention and Enteral Access Market Size YoY Growth 2015-2026
- 7.2 North America Infection Prevention and Enteral Access Market Facts & Figures by Country
- 7.2.1 North America Infection Prevention and Enteral Access Sales by Country (2015-2020)
- 7.2.2 North America Infection Prevention and Enteral Access Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Infection Prevention and Enteral Access Market Size YoY Growth 2015-2026
- 8.2 Europe Infection Prevention and Enteral Access Market Facts & Figures by Country
- 8.2.1 Europe Infection Prevention and Enteral Access Sales by Country
- 8.2.2 Europe Infection Prevention and Enteral Access Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Infection Prevention and Enteral Access Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Infection Prevention and Enteral Access Market Facts & Figures by Country
- 9.2.1 Asia Pacific Infection Prevention and Enteral Access Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Infection Prevention and Enteral Access Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Infection Prevention and Enteral Access Market Size YoY Growth 2015-2026
- 10.2 Latin America Infection Prevention and Enteral Access Market Facts & Figures by Country
- 10.2.1 Latin America Infection Prevention and Enteral Access Sales by Country
- 10.2.2 Latin America Infection Prevention and Enteral Access Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Infection Prevention and Enteral Access Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Infection Prevention and Enteral Access Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Infection Prevention and Enteral Access Sales by Country
- 11.2.2 Middle East and Africa Infection Prevention and Enteral Access Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Cook Medical
- 12.1.1 Cook Medical Corporation Information
- 12.1.2 Cook Medical Description and Business Overview
- 12.1.3 Cook Medical Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Cook Medical Infection Prevention and Enteral Access Products Offered
- 12.1.5 Cook Medical Recent Development
- 12.2 Medtronic plc
- 12.2.1 Medtronic plc Corporation Information
- 12.2.2 Medtronic plc Description and Business Overview
- 12.2.3 Medtronic plc Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Medtronic plc Infection Prevention and Enteral Access Products Offered
- 12.2.5 Medtronic plc Recent Development
- 12.3 Boston Scientific Corporation
- 12.3.1 Boston Scientific Corporation Corporation Information
- 12.3.2 Boston Scientific Corporation Description and Business Overview
- 12.3.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Boston Scientific Corporation Infection Prevention and Enteral Access Products Offered
- 12.3.5 Boston Scientific Corporation Recent Development
- 12.4 CONMED Corporation
- 12.4.1 CONMED Corporation Corporation Information
- 12.4.2 CONMED Corporation Description and Business Overview
- 12.4.3 CONMED Corporation Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 CONMED Corporation Infection Prevention and Enteral Access Products Offered
- 12.4.5 CONMED Corporation Recent Development
- 12.5 CORPAK MedSystems
- 12.5.1 CORPAK MedSystems Corporation Information
- 12.5.2 CORPAK MedSystems Description and Business Overview
- 12.5.3 CORPAK MedSystems Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 CORPAK MedSystems Infection Prevention and Enteral Access Products Offered
- 12.5.5 CORPAK MedSystems Recent Development
- 12.6 CR Bard
- 12.6.1 CR Bard Corporation Information
- 12.6.2 CR Bard Description and Business Overview
- 12.6.3 CR Bard Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 CR Bard Infection Prevention and Enteral Access Products Offered
- 12.6.5 CR Bard Recent Development
- 12.7 ALCOR Scientific
- 12.7.1 ALCOR Scientific Corporation Information
- 12.7.2 ALCOR Scientific Description and Business Overview
- 12.7.3 ALCOR Scientific Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 ALCOR Scientific Infection Prevention and Enteral Access Products Offered
- 12.7.5 ALCOR Scientific Recent Development
- 12.8 Pacific Hospital Supply
- 12.8.1 Pacific Hospital Supply Corporation Information
- 12.8.2 Pacific Hospital Supply Description and Business Overview
- 12.8.3 Pacific Hospital Supply Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Pacific Hospital Supply Infection Prevention and Enteral Access Products Offered
- 12.8.5 Pacific Hospital Supply Recent Development
- 12.9 Teleflexorporated
- 12.9.1 Teleflexorporated Corporation Information
- 12.9.2 Teleflexorporated Description and Business Overview
- 12.9.3 Teleflexorporated Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Teleflexorporated Infection Prevention and Enteral Access Products Offered
- 12.9.5 Teleflexorporated Recent Development
- 12.10 Vygon SA
- 12.10.1 Vygon SA Corporation Information
- 12.10.2 Vygon SA Description and Business Overview
- 12.10.3 Vygon SA Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Vygon SA Infection Prevention and Enteral Access Products Offered
- 12.10.5 Vygon SA Recent Development
- 12.11 Cook Medical
- 12.11.1 Cook Medical Corporation Information
- 12.11.2 Cook Medical Description and Business Overview
- 12.11.3 Cook Medical Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Cook Medical Infection Prevention and Enteral Access Products Offered
- 12.11.5 Cook Medical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Infection Prevention and Enteral Access Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Infection Prevention and Enteral Access Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Infection Prevention and Enteral Access market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Infection Prevention and Enteral Access market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Infection Prevention and Enteral Access market is segmented into
Enteral Feeding Pumps
Enteral Feeding Tubes
Administration Reservoirs
Giving Sets
Enteral Syringes
Segment by Application, the Infection Prevention and Enteral Access market is segmented into
Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others
Regional and Country-level Analysis
The Infection Prevention and Enteral Access market is analysed and market size information is provided by regions (countries).
The key regions covered in the Infection Prevention and Enteral Access market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Infection Prevention and Enteral Access Market Share Analysis
Infection Prevention and Enteral Access market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Infection Prevention and Enteral Access business, the date to enter into the Infection Prevention and Enteral Access market, Infection Prevention and Enteral Access product introduction, recent developments, etc.
The major vendors covered:
Cook Medical
Medtronic plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard
ALCOR Scientific
Pacific Hospital Supply
Teleflexorporated
Vygon SA